Strategic Marketing Pfizer Case 2 Version Final

35
case study Pfize r

description

A group presentation given during a strategic marketing course at ESCE. The presentation is about Pfizer.

Transcript of Strategic Marketing Pfizer Case 2 Version Final

Page 1: Strategic Marketing Pfizer Case 2 Version Final

case study

Pfizer

Page 2: Strategic Marketing Pfizer Case 2 Version Final

drugs industry nowadays

Page 3: Strategic Marketing Pfizer Case 2 Version Final

PlanDIAGNOSTIC

Market segmentationTargeting and positioning strategyAdvertising and salesforce

strategy

SOLUTIONS

Structure of the organizationWeaknesses of Pfizer’s pipelinePfizer’s options

Page 4: Strategic Marketing Pfizer Case 2 Version Final

Diagnostic ofPfizer’s strategies

What are the options ?

Page 5: Strategic Marketing Pfizer Case 2 Version Final

Smaller and smaller market segment

From

mass market

drugs

To niche segment

Page 6: Strategic Marketing Pfizer Case 2 Version Final

But Pfizer still use a blockbuster

strategy

Page 7: Strategic Marketing Pfizer Case 2 Version Final

Targetting the mass market

Page 8: Strategic Marketing Pfizer Case 2 Version Final

And high-growth drug operation

Page 9: Strategic Marketing Pfizer Case 2 Version Final

Bigger portfolio and targeted/niche product

Politicians Marketing Target strategy for Viagra

Targeting strategyOther points

Page 10: Strategic Marketing Pfizer Case 2 Version Final

Pfizer’sPosition Strategy

Well let’s say Here

Page 11: Strategic Marketing Pfizer Case 2 Version Final

Advertising shells Mixing glib advertising and medicine Pitch erectile dysfunction drugs

Positioning strategy

Page 12: Strategic Marketing Pfizer Case 2 Version Final

Smaller and smaller market segment

Before Now

Page 13: Strategic Marketing Pfizer Case 2 Version Final

Smaller and smaller market segment

Personalize

d

advertisind

Before Now

Page 14: Strategic Marketing Pfizer Case 2 Version Final

Smaller and smaller market segment

Personalize

d

advertisind

And Sales forces

Before Now

Page 15: Strategic Marketing Pfizer Case 2 Version Final

38 000

Page 16: Strategic Marketing Pfizer Case 2 Version Final

Diagnostic ofPfizer’s strategies

What are the options ?

Page 17: Strategic Marketing Pfizer Case 2 Version Final

Pfizer needs to change its structure

Smaller groups Bottom top communication

Page 18: Strategic Marketing Pfizer Case 2 Version Final

Frontal attacks from competitors

Page 19: Strategic Marketing Pfizer Case 2 Version Final

Fortress defense srategy

has to be adopted

Page 20: Strategic Marketing Pfizer Case 2 Version Final

Skimming and harvesting strategy

Page 21: Strategic Marketing Pfizer Case 2 Version Final

People prefer doing self treatment

Page 22: Strategic Marketing Pfizer Case 2 Version Final

Adapt to each segment needs

Page 23: Strategic Marketing Pfizer Case 2 Version Final

Products’ pipelineOther Weaknesses

Expensive development : $70 billion for each product in 2004 → Centralize labs

Lack of data proving that treatment is really necessary [cholesterol] → lead strong research

Distribution controlled by the government → work hand in hand with the government

Page 24: Strategic Marketing Pfizer Case 2 Version Final

What are the options for Pfizer ?

Page 25: Strategic Marketing Pfizer Case 2 Version Final

Change the blockbuster strategy

Page 26: Strategic Marketing Pfizer Case 2 Version Final

Diverse portfolio targeting

complexe and niche markets

Page 27: Strategic Marketing Pfizer Case 2 Version Final

Fight against cheap generic

competition

Page 28: Strategic Marketing Pfizer Case 2 Version Final

Create Specialized Business Unit

Page 29: Strategic Marketing Pfizer Case 2 Version Final

Other options

Diversify in the health industry

Page 30: Strategic Marketing Pfizer Case 2 Version Final

Other options

Diversify in the health industryDo Strategic alliances or paternships

Page 31: Strategic Marketing Pfizer Case 2 Version Final

Other options

Diversify in the health industryDo Strategic alliances or paternships

Enhance productivity in labs

Page 32: Strategic Marketing Pfizer Case 2 Version Final

Other options

Diversify in the health industryDo Strategic alliances or paternships

Enhance productivity in labsHave a better communication

strategy

Page 33: Strategic Marketing Pfizer Case 2 Version Final

Other options

Diversify in the health industryDo Strategic alliances or paternships

Enhance productivity in labsHave a better communication

strategyCHANGE THE SALES MODEL

Page 34: Strategic Marketing Pfizer Case 2 Version Final

Questions

?

Page 35: Strategic Marketing Pfizer Case 2 Version Final

Photographies

www.sxc.hu www.office.microsoft.com